Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 109Unknown 38Terminated 34Recruiting 26Active not recruiting 16Withdrawn 10Not yet recruiting 4Suspended 3

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 1Genitourinary 1

Conditions

Lung Neoplasms 3Small Cell Lung Carcinoma 2Prostatic Neoplasms 1Peritoneal Neoplasms 1Ototoxicity 1Oropharyngeal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Mesothelioma 1Hepatoblastoma 1Chemotherapeutic Agent Toxicity 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Cisplatin 3pembrolizumab 2Etoposide 2Docetaxel 2Carboplatin 2durvalumab 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Radionuclide Imaging 1Radiation 1Prednisone 1Positron-Emission Tomography 1Platinum 1Paclitaxel 1Nivolumab 1Methods 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Injections 1Exercise Therapy 1Erlotinib Hydrochloride 1Eflornithine 1Clinical Protocols 1CTLA-4 Antigen 1Blood Specimen Collection 1Biopsy 1Biological Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Suspended × Lung Neoplasms × Cisplatin × Clear all
NCT05403723 2026-02-19

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

University of Maryland, Baltimore

Phase 1 Suspended
50 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT01356303 2016-05-13

TAXIS01

National Guard Health Affairs

Phase 2 Suspended
50 enrolled
Thoracic

Lung Neoplasms

NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

GlaxoSmithKline

Phase 1 Suspended
54 enrolled
GenitourinaryOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡